Viewing Study NCT02106156


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-02-23 @ 6:27 AM
Study NCT ID: NCT02106156
Status: COMPLETED
Last Update Posted: 2016-09-23
First Post: 2014-04-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ML21645
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators